Entering text into the input field will update the search result below

Merck & Company – Not What It Was And Should Be – But – Doing Well - BUT

Apr. 03, 2014 10:49 AM ETMRK, PFE, TEVA, BMY, JNJ, LLY, ABT, GWPH, FRX-OLD, VTRS, ORMP, GSK, ZTS1 Comment
Steven Bauer profile picture
Steven Bauer's Blog
1.57K Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Merck & Company - Not What It Was and Should Be - But - Doing Well - BUT

Merck $ Company is tracking the Dow 30 Industrials very well and that is usually a very good indicator. Unfortunately, my Fundamental and Technical Forecast - tell me a very different and much less optimistic story. Listening to my Forecasts is always the prudent thing to do. I am not Forecasting much if any up-side at this time.

My previously written articles on MRK (just click) provide you the history of my forecasting, its accuracy and support for my performance. For over 50 years my management objective is to identify changing trends for my forecasting analytics. I simple want to have current notes to quickly refer to on the anticipated direction of this company and its industry peers.

My Performance for Merck can be found below and is about 42% since March 2012.

More Support for My Dow 30 Forecasting Accuracy

The following article supports my Methodology of "Investing Wisely" and with superior and consistent annual profits. Just Click.

My management objective is to identify changing trends for my Forecasting Analytics. Simple stated, I want to have current notes to quickly refer to on the anticipated direction of this Sector and Industry Group.

A Special Note for Seniors & Retired Investors - Dividend Yield: 3.12%

I believe you folks deserve much better service and investment direction and guidance that either Wall Street or the Brokerage Community is / has been providing. Being a retired Asset Manager / Financial Analyst is a joy for me to assist you and meet your investment - needs, goals and objective. Peace of Mind for you is my mission.

Note: The Difference Between You and the Pros: Clearly you should be profitable and making money by owning Merck. Via my Emails, I have found that many Investors are struggling with other securities they are holding. I have offered direction to hundreds of Investors and can share with you why you are perhaps holding losing securities and provide a conservative and low risk remedy.

Forecast w/ Performance

Merck & Company and other Health Care Sector Companies are tracking well. The Company has supported my Forecasts for many years, so be prudent and careful at this time.

Note: The below Table is for your review, questions and perhaps thoughts. If you are seeking to "Invest Wisely" in my "Income & Growth - Asset Allocation Model" - - please Email me to open a dialog on how I go about providing superior performance with a very low threshold of Risk.

My Current Forecast is not as bright as you may think! (I will be more specific upon request).

If you own or are considering owning Pharmaceutical Companies, the securities are currently and definitely strong but I have reservations. I have placed it on an Initial Bearish Forecast - "Warning."

My Current Opinion is to HOLD in anticipation of taking profits.

Fundamentally - ( weighting - - 40% ): My Analytics for my Fundamental Valuation play a vital role in profitable managing money. At this time my Valuations of (MRK) are not as positive at perhaps you are being told by other sources. Plainly stated they are looking anemic again. This does not make for a positive fundamental valuation of any Company for a long-term Hold.

Technically - ( weighting - - 35%): Even with this fine Company, my Indicators are notably breaking down. It is currently on its highs of $55.

Consensus Opinion - ( weighting - - 25% ): My third pillar of Research is one that is ALWAYS distorted to the Positive by most all financial analysts. That's because they are afraid of being Bearish. I Am NOT! My articles on "Reality" are supportive of the below 20 year Chart.

I will personally and promptly reply to any serious investor's inquiry as to my very cautious position for (MRK) !

A Twenty Year Perspective of Merck & Company (MRK)

It has NOT always been like you are being told by so many who do not take the time to Invest Wisely. Merck & Company (MRK) has taken some big hits over the years. Have a look.

URL for (20-years of -(MRK): http://stockcharts.com/h-sc/ui?s=MRK&p=W&yr=20&mn=0&dy=0&id=p93590629233&a=330115415

Selectivity

"Selectivity" is what I preach (along with Discipline and Patience) and is what separates the Average Investor and Mutual Funds from the profits that come with long-hours / hard work and "Selectivity."

Here are a number of the Component Companies / Peers in the Major Pharma. Industry Group that I focus on rather frequently: (MRK), (PFE), (TEVA), (BMY), (JNJ), (LLY), (ABT), (GWPH), (FRX), (MYL), (ORMP), (GSK), (ZTS). And, many more . . .

Note: Should you have interest in my professional guidance and direction for your Portfolios, please Email Me with your questions or thoughts: senorstevedrmx@yahoo.com.

For Daily Updates and a Deeper View into my work / Analytics, you might want to Click and Scroll Down to my "Thumb-Nail" Articles within my personal blog.

Please spend some time reading my articles for a perspective of their and also viewing my Bio before making inquiries. Sharing a bit about yourself and your financial and needs, goals and objectives would be appreciated.

A relationship between You and Your Asset Manager must be a "Win / Win" affair. You get the Performance and the Education and I get paid for my Analytics / Work and Experience.

Smile, Have Fun, "Investing Wisely,"

Dr. Steve

MRK, PFE, TEVA, BMY, JNJ, LLY, ABT, GWPH, FRX, MYL, ORMP, GSK, ZTS

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You